title: γH2AX is a biomarker of modulated cytostatic drug resistance.
authors.affiliation: CSIRO Food and Nutrition Flagship, Genome Health and Healthy Ageing, Adelaide, South Australia, 5000, Australia.
authors.forename: Wayne R
authors.initials: WR
authors.lastname: Leifert
authors.affiliation: CSIRO Food and Nutrition Flagship, Genome Health and Healthy Ageing, Adelaide, South Australia, 5000, Australia.|School of Agriculture, Food and Wine, University of Adelaide, Urrbrae, South Australia, 5064, Australia.
authors.forename: Sabbir Mohammad
authors.initials: SM
authors.lastname: Siddiqui
mesh_terms: D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D015415:Biomarkers / Q000378:metabolism*; D054697:Cytostatic Agents / Q000627:therapeutic use*; D004249:DNA Damage / Q000187:drug effects / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics*; D005047:Etoposide / Q000627:therapeutic use; D006657:Histones / Q000235:genetics* / Q000378:metabolism*; D006801:Humans; D009369:Neoplasms / Q000178:diet therapy / Q000235:genetics / Q000378:metabolism
chemical_list: D015415:Biomarkers; D054697:Cytostatic Agents; C468783:H2AX protein, human; D006657:Histones; D005047:Etoposide
keywords: cytotoxic; drug resistance; etoposide; γH2AX